Healthbeat - Your Source for Daily Health Trends and Medical News

Journalists Examine Health Care for Native Americans and Recent Food Recalls

KFF Health News and California Healthline staff made the rounds on national and local media in recent weeks to discuss topical stories. Here’s a collection of their appearances.

What is melanoma, who does it affect and how can people avoid it?

For people aged 25 to 49 melanoma is the second most common form of cancer, but the risk can be reducedOver the past two decades, cancer cases in the UK have been rising twice as fast for people under

Student-invented device Walkfit aids mobility and orthopaedic diagnosis

Rahi Shah and Hriday Boriawala, two class 12 students and creators of Walkfit, a device to aid people with lower limb orthopaedic disorders explain their invention, inspiration and process of develop

Kennedy’s Views Mix Mistrust of Business With Unfounded Health Claims

President-elect Donald J. Trump’s pick for health secretary opposes fluoride in water, promotes unproven Covid therapies and has threatened to prosecute medical journals.

Heart Failure in Zero Gravity—External Constraint and Cardiac Hemodynamics

In this case series study, pulmonary artery systolic, diastolic, and mean pressures of 2 participants with obesity and heart failure with preserved ejection fraction were measured at zero gravity duri

STAT+: Some patients are paying up to $50,000 per year in fees for ‘concierge medicine.’ Here’s what’s behind its rise

Money can buy lots of stuff.

What To Know About RFK Jr.’s Stances on Key Health Issues and What He Could Do at HHS

Robert F. Kennedy Jr.

FDA Approves First Menin Inhibitor for Acute Leukemia

(MedPage Today) -- The FDA granted full approval to the menin inhibitor revumenib (Revuforj) for adults and children 1 year and older with relapsed/refractory acute leukemia and a lysine methyltransf

Stalemate breaks on telehealth prescriptions of stimulants and addiction treatment

The DEA grants a one-year extension on telehealth prescription of addiction medications, kicking resolution on a fraught issue to the second Trump administration.

Clozapine's REMS Program on the Chopping Block at Upcoming FDA Meeting

(MedPage Today) -- Is a risk evaluation and mitigation strategy (REMS) still needed for clozapine? That's what a joint meeting of two FDA advisory committees will discuss on Tuesday.

All News